Stocks climbed in the US on Monday as the market kicked off a holiday-shortened trading week, buoyed by strength in ...

The realm of politics, a seemingly endless tapestry woven from interwoven threads of ideology, policy, and power dynamics, ...

In Washington, the US Senate passed a bill to end a brief government shutdown that began after a missed midnight deadline.

Wesfarmers (ASX:WES) has announced an agreement to sell its Coregas business to a subsidiary of Nippon Sanso Holdings ...

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...

A round up of some stocks capturing attention this week, featuring INOVIQ, Tamboran Resources, Omni Bridgeway, Clarity Pharmaceuticals and Mesoblast.

Ventia (ASX:VNT) and Telstra (ASX:TLS) have signed a five-year strategic agreement. The agreement is expected to generate ...

Cleanaway Waste Management (ASX:CWY), Australia's largest provider of waste, recycling, and environmental services, has ...

Mesoblast (ASX:MSB) has received approval from the US Food and Drug Administration (FDA) for Ryoncil (remestemcel-L), making it the first mesenchymal stromal cell (MSC) therapy to be approved in the ...

Radiopharm Theranostics (ASX:RAD) has received approval from the Bellberry Human Research Ethics Committee to commence the Phase 1 clinical trial of its "177Lu-RAD202" therapy. Before a clinical trial ...